2004
DOI: 10.1016/j.arcped.2004.03.028
|View full text |Cite
|
Sign up to set email alerts
|

Effet analgésique de la crème Emla®, du saccharose et de leur association pour les injections sous-cutanées chez le nouveau-né prématuré : étude prospective de 265 injections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
4
0
1

Year Published

2010
2010
2016
2016

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(6 citation statements)
references
References 27 publications
1
4
0
1
Order By: Relevance
“…A sweet-tasting solution placed in an infant’s mouth can reduce responses to painful stimuli; sweet taste perception mediates both endogenous opioid and nonopioid systems to block pain afferents (34). LCS, such as aspartame, mimic the time course and the magnitude of the increased calming (35, 36) and mouthing and hand-to-mouth contact effects (35) of sucrose. Given that the administration of sucrose by direct stomach loading was ineffective (37), it may be that afferent signals from the mouth, rather than gastric or metabolic changes, are responsible for the analgesic properties of sweet tastes.…”
Section: Responses To Sweet Taste During Developmentmentioning
confidence: 99%
“…A sweet-tasting solution placed in an infant’s mouth can reduce responses to painful stimuli; sweet taste perception mediates both endogenous opioid and nonopioid systems to block pain afferents (34). LCS, such as aspartame, mimic the time course and the magnitude of the increased calming (35, 36) and mouthing and hand-to-mouth contact effects (35) of sucrose. Given that the administration of sucrose by direct stomach loading was ineffective (37), it may be that afferent signals from the mouth, rather than gastric or metabolic changes, are responsible for the analgesic properties of sweet tastes.…”
Section: Responses To Sweet Taste During Developmentmentioning
confidence: 99%
“…However, the difference between groups was not statistically significant. In other studies, it was stated that respiratory rate, heart rate, blood pressure and oxygen saturation were not significant in pain analysis before and after the procedure ( 10 , 19 ).…”
Section: Discussionmentioning
confidence: 87%
“…For the pharmacological treatment of pain in newborns, opioid and non-opioid analgesic, sedatives and local anaesthetics are used ( 8 ). EMLA application, a pharmacological method that is easy to apply in the elimination and reduction of pain in newborns, is safely and effectively used for newborns undergoing intravenous (IV) vascular catheterisation, IV bloodletting, lumbar puncture, central venous catheterisation, circumcision and intramuscular (IM) injection ( 9 , 10 ). In Unaldis ( 11 ) study, it was determined that EMLA cream was effective in pain reduction during painful procedures on newborns.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, despite the prolific research conducted to date, repeated doses of sweet solutions over prolonged periods have only been investigated in a small number of studies. [72][73][74][75] Although these studies showed ongoing effectiveness of sucrose over weeks to months of use, further research in this area, especially with the aim of exploring if consistently reducing procedural pain over prolonged hospitalizations ameliorates negative sequela of untreated pain for preterm and high-risk neonates, will add valuable information to the science of neonatal pain management.…”
Section: Facilitators and Barriers To Implementationmentioning
confidence: 97%